Hasty Briefsbeta

Russia's Cancer Vaccine Shows 100% Efficacy in Trials, Is It a Breakthrough Yet?

4 hours ago
https://in.mashable.com/science/99542/russias-cancer-vaccine-reportedly-shows-100-efficacy-in-early-trials-but-is-it-a-breakthrough-yet
Copy Link
  • #cancer vaccine
  • #mRNA technology
  • #personalized medicine
  • Russian scientists developed a personalized mRNA cancer vaccine called Enteromix.
  • The vaccine targets specific proteins unique to a patient’s cancer cells.
  • Early Phase I trials with 48 colorectal cancer patients showed promising results, with all patients developing an immune response and 60-80% experiencing tumor shrinkage or halted growth.
  • The vaccine also showed positive early results in small test groups with glioblastoma and melanoma.
  • The Federal Medical and Biological Agency (FMBA) is fast-tracking Enteromix for potential clinical use in Russia.
  • Experts caution that Phase I trials are small and focus on safety, not long-term effectiveness.
  • More extensive Phase II and III trials are needed to confirm the vaccine’s efficacy across larger groups.
AboutLogin